China Pharmaceutical Packaging Innovation and Management Conference

Release time:

2018-08-27 20:15

On the basis of 2013, the 2014 China Pharmaceutical Packaging Innovation and Management Conference is about to return strongly. In addition to the high-quality guest lineup as always, more valuable topic content and interactive forms will also be dedicated. The summit will specially invite authoritative experts from relevant government identification and testing institutions, as well as relevant persons in charge of pharmaceutical packaging materials from Pfizer, Sanofi, Johnson & Johnson, Baxter, Otsuka, Bristol-Myers Squibb and other top 100 pharmaceutical companies to come to the scene to conduct in-depth discussions and case sharing from the revised registration standards for pharmaceutical packaging materials, safe and compatible pharmaceutical packaging materials, scientific and humanized pharmaceutical packaging design, exquisite and leading packaging technology, etc., so as to provide a platform for learning and dialogue for the participants. It will also build a valuable network of like-minded peers in the industry.
 
Reason for Participation
Exhibition linkage, kill multiple birds with one stone: not only can you participate in the largest and highest-grade pharmaceutical exhibition in the Asia-Pacific region, see the latest pharmaceutical packaging materials, but also learn the thinking and practice of the world's leading pharmaceutical companies in the field of pharmaceutical packaging!
Authoritative speakers: The summit specially invited authoritative experts from relevant government identification and testing institutions, as well as relevant persons in charge of pharmaceutical packaging materials from the world's top 100 pharmaceutical companies such as Pfizer, Sanofi, Johnson & Johnson, Baxter, Otsuka, Bristol-Myers Squibb, etc
Professional dialogue platform: The summit will attract more than 120 relevant leaders from governments, leading pharmaceutical companies and pharmaceutical packaging companies. It will provide a platform for all participants to learn and dialogue, and will build a valuable interpersonal network for like-minded industry peers.
 
Conference Highlights:
Collaboration – Collaborate with the industry's top suppliers
Understand – help pharmaceutical companies gain an in-depth understanding of the latest developments in pharmaceutical packaging in China
Insight – a deep understanding of fresh ideas and a stimulating environment
Interaction - Professionals who are enthusiastic about the future development of pharmaceutical packaging materials will gather together to exchange and interact
Listen – Listen to industry leaders share cutting-edge new technologies and practical applications in the industry
 
Meeting agenda
Lecture 1: Revised Registration Standards for Pharmaceutical Packaging Materials
In order to strengthen the supervision and management of packaging materials and containers in direct contact with drugs and ensure the quality of pharmaceutical packaging materials, on July 20, 2004, the State Food and Drug Administration promulgated the Administrative Measures for Packaging Materials and Containers in Direct Contact with Drugs (Order No. 13) to carry out unified supervision of packaging materials and containers in direct contact with drugs.
Director/Institute for the Control of Packaging Materials and Pharmaceutical Excipients, China Institute for Food and Drug Control
Director/Pharmaceutical Packaging Materials Office, Zhejiang Institute for Food and Drug Control
Deputy Director / Shanghai Food and Drug Packaging Materials Testing Institute
Lecture 2: Discussion on Regulatory Compliance of Pharmaceutical Packaging Materials
In addition to the need to provide protective performance, the safety and consistency of pharmaceutical packaging materials are also very important considerations. The regulatory requirements for pharmaceutical packaging materials issued by the state have become an important yardstick for enterprises to develop pharmaceutical packaging materials. However, at present, the development and management of domestic pharmaceutical packaging materials are facing a dilemma. In response to increasingly stringent regulatory requirements and increasingly difficult to match upstream raw materials, pharmaceutical companies have lamented huge pressure. In this talk, the speaker will focus on Johnson & Johnson's response to this problem and share relevant cases.
Senior Manager, Global Engineering/Johnson & Johnson (China) Co., Ltd
Lecture 3: Discuss the new trend of pharmaceutical packaging materials from the perspective of design, technology and material
With the development of economy and technology, the pharmaceutical packaging materials used for special commodities are constantly upgrading, and with the strengthening of people's awareness of environmental protection, pharmaceutical packaging is developing in the direction of being safer, more convenient and pollution-free. The application of new materials, new technologies and new processes in the field of pharmaceutical packaging has become a new trend in the future development of pharmaceutical packaging materials!
Lecture 4: Packaging Design and Cost Savings
With the deepening of marketization and the intensification of competition, pharmaceutical companies are facing more and more price pressures in various aspects, such as raw materials, labor, logistics, competition, government pricing, etc. In order to adapt to the different requirements of drugs, various new packaging materials are more and more widely used in the field of pharmaceutical packaging, which also pushes up the cost of packaging materials to a certain extent. How to develop and design packaging through the use of new technologies, new materials, new processes and new ideas, and how to reduce costs under the premise of ensuring product quality have become a focus of many enterprises and packaging developers.
Packaging Development Manager, China / Sanofi (China)
Lecture 5: Safety and compatibility of pharmaceutical packaging materials and drugs
The finished drug product and the packaging system used with it should be suitable for their intended application, and the safety of the drug packaging material to be registered or marketed must be effectively evaluated. The safety evaluation of pharmaceutical packaging materials includes chemical evaluation (extractables and leachables evaluation), biological evaluation, and toxicological evaluation. At the same time, it is also necessary to study the compatibility evaluation of drugs, including drug stability and the adsorption performance of packaging materials to drugs. This paper focuses on the methods and concepts of chemical evaluation of the safety of pharmaceutical packaging materials, as well as the biological and toxicological evaluation process, as well as the latest research progress.
Technical Manager / Suzhou Baxter Medical Products Co., Ltd
Lecture 6: Discussion on the development trend of pharmaceutical packaging materials in the future
With the continuous emergence of new drugs and the continuous upgrading of strict regulations on pharmaceutical packaging materials, the safety and diversified development of pharmaceutical packaging materials and forms have become a hot spot for enterprises. Some experts predict that by 2020, China is expected to become the world's second largest pharmaceutical market. This puts forward higher requirements for the material and form of pharmaceutical packaging materials. In this talk, professionals who are enthusiastic about the diversified development of pharmaceutical packaging materials in the future will gather together to share their thoughts and views.

China Pharmaceutical Packaging Innovation and Management Conference

RELATED NEWS